Citation Impact
Citing Papers
Acute Phase Proteins with Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A Protein
1983 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Cardiopulmonary function in two human disorders of the hypoxia‐inducible factor (HIF) pathway: von Hippel‐Lindau disease and HIF‐2α gain‐of‐function mutation
2011 StandoutNobel
The Pathogenicity of Behavior and Its Neuroendocrine Mediation
1995
Classification criteria for psoriatic arthritis: Development of new criteria from a large international study
2006 Standout
Pathogenesis and clinical features of psoriasis
2007 Standout
Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?
2014 Standout
Antiatherothrombotic effects of nicotinic acid
2003
Phaeochromocytoma
2005 Standout
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Pre-eclampsia
2005 Standout
von Hippel-Lindau disease
2003 Standout
A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure
1991 Standout
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Diabetic Foot Disorders: A Clinical Practice Guideline (2006 Revision)
2006 Standout
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
2001
Neuroblastoma
2007 Standout
Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary review
2005
Musculoskeletal Aspects of Pregnancy
2005 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Pre-eclampsia
2015 Standout
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Synthetic fibrinolytic agents
1979
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Pregnancy and post-pregnancy avascular necrosis of the femoral head
1982
Comparative Effects of Intra‐arterially Administered Isoprenaline and Sodium Nitrite on Blood Flow and Volume of the Forearm
1967
Alpha-Adrenergic Receptor Subtypes
1980 StandoutNobel
Abnormal Plasminogen-Plasmin System Activity (Fibrinolysis) in Patients with Hepatic Cirrhosis: Its Cause and Consequences*
1964
Mutation and cancer: neuroblastoma and pheochromocytoma.
1972
1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASE
1977 Standout
Beneficial effects of hydralazine on rest and exercise hemodynamics in patients with chronic severe aortic insufficiency.
1980
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Intraoperative Changes in Blood Coagulation and Thrombelastographic Monitoring in Liver Transplantation
1985 Standout
Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure
1977
Red blood cell velocity in nailfold capillaries of man measured by a television microscopy technique
1974
Cryoglobulins in Coronary-Artery Disease
1953
Studies of the Blood Plasminogen Activator Induced by 1-Desamino-8-D-arginine Vasopressin with Observations in von Willebrand's Disease
1982
The biochemistry and physiology of urokinase
1960
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
1986 Standout
The natural history of idiopathic dilated cardiomyopathy
1981 Standout
Actinomycosis and nocardiosis
1960 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Actinomycosis: Diagnostic and therapeutic considerations and a review of 32 cases
1984 Standout
Extra-Adrenal Pheochromocytoma
1992
TREATMENT OF ACTINOMYCOSIS WITH ISONIAZID
1953
Psoriatic arthritis
1973 Standout
Investigation of Chronic Venous Insufficiency
2000 Standout
Circulating immune complexes, serum immunoglobulins, and acute phase proteins in psoriasis and psoriatic arthritis.
1981
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Oral hydralazine therapy for chronic refractory heart failure.
1976
Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive Drugs
1975
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
2014
Nonoperative management of diabetic foot infections
2003
Mechanism for improved cardiac performance with arteriolar dilators in aortic insufficiency.
1981
The Influence of Social Hierarchy on Primate Health
2005 StandoutScience
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
The role of vasodilator therapy in heart failure
1977
Diabetic Foot Infections: Pathophysiology and Treatment
1994
Comparative Studies on Human Activators of Plasminogen
1981
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Diabetic foot infections. Pathophysiology and treatment.
1994
Mixed cryoglobulinemia: Clinical aspects and long-term follow-up of 40 patients
1980 Standout
Works of Walter Redisch being referenced
Occurrence of Fibrinolytic Activity Following Administration of Nicotinic Acid
1958
Capillaroscopic observations in rheumatic diseases.
1970
Bone and Microcirculatory Changes in a Child With Benign Pheochromocytoma
1967
Classification and measurement of surface microvessels in man
1972
Skin Temperature Response of Normal Human Subjects to Various Conditions
1952
INDUCED INTERMITTENT CLAUDICATION
1951
Influence of Some Vasoactive Drugs on Fibrinolytic Activity
1959
STUDIES ON HYDRALAZINE; EVIDENCE FOR A PERIPHERAL SITE OF ACTION 1
1954
Vasomotor Responses to Cooling in the Extremities of Subjects with Neurologic Lesions
1959
Incidence of Peripheral Vascular Changes In Diabetes Mellitus: A Survey of 264 Cases
1953
Pheochromocytomata
1967